angioplasty

(redirected from percutaneous transluminal coronary angioplasty)
Also found in: Dictionary, Thesaurus, Medical, Acronyms.
Related to percutaneous transluminal coronary angioplasty: Percutaneous Transluminal Angioplasty

angioplasty

(ăn`jēōplăs'tē), any surgical repair of a blood vessel, especially balloon angioplasty or percutaneous transluminal coronary angioplasty, a treatment of coronary artery diseasecoronary artery disease,
condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. Coronary artery disease is the most common underlying cause of cardiovascular disability and death.
..... Click the link for more information.
. In balloon angioplasty a balloon-tipped catheter is inserted through the skin into a blood vessel and maneuvered to the clogged portion of the artery. There it is threaded into the blockage and inflated, compressing the plaque against the arterial walls. Frequent postoperative reclogging (restenosis) of the treated area has led to the use of alternative techniques such as laser angioplasty, which employs a laser to burn away or vaporize the plaque, and to the study of various drugs, gene therapies, and mechanical devices such as a stainless steel coil, or stent (most often now coated with a drug that inhibits restenosis), designed to hold the plaque back.
The Columbia Electronic Encyclopedia™ Copyright © 2013, Columbia University Press. Licensed from Columbia University Press. All rights reserved. www.cc.columbia.edu/cu/cup/

angioplasty

[′an·jē·ə‚plas·tē]
(medicine)
A procedure for alleviating blockage of an artery in which a balloon-tipped catheter is threaded into an artery to a point of obstruction and inflated to push the vessel open.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
Clinical and technical determinants of the complexity of percutaneous transluminal coronary angioplasty procedures: Analysis in relation to radiation exposure parameters.
* Identify and understand important and diverse types of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters under development
Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up.
The aim of the present study was to observe the feasibility of drug coating on percutaneous transluminal coronary angioplasty (PTCA) balloon catheter by dip coating technique and analyze the in-vitro release pattern of Sirolimus on inflation.
The procedures include but are not limited to coronary bypass surgery, percutaneous transluminal coronary angioplasty, and medical (drug) treatment.
The effectiveness of invasive cardiovascular procedures, including percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG), and their contribution to the observed decline in mortality rates from ischemic heart disease, have been the subject of debate (Goldman and Cook 1986, Killip 1986).
Percutaneous transluminal coronary angioplasty (PTCA) catheter tubing is a particularly demanding application.
Percutaneous transluminal coronary angioplasty (PTCA) would be an attractive method for myocardial revascularization in elderly patients.
What's percutaneous transluminal coronary angioplasty?
Jude Medical), and left atrial access could finally be achieved by dilatation of the interatrial septum with gradually increasing sizes of percutaneous transluminal coronary angioplasty (PTCA) balloons (up to 5 mm) over the SafeSept wire (Figure 1(c); Supplemental Movie 1 in Supplementary Material available online at https://doi.org/10.1155/ 2017/3652413).
Objective: To find the effect of ischemia on QT dispersion in coronary artery disease patients and to compare QT dispersion before and after percutaneous transluminal coronary angioplasty.
The trial will study patients with an acute myocardial infarction (AMI) and a left ventricle ejection fraction (LVEF) remaining below or equal to 45 percent after percutaneous transluminal coronary angioplasty (PTCA) and stcnt(s) implantation versus standard of care.

Full browser ?